MRF Stewardship Report Volume 5 FINAL



On April 1, 2021 the MRF announced Douglas Brodman as the new Chair of its Board of Directors. An accomplished senior executive and stage 4 melanoma survivor, Brodman succeeds Steven Silverstein, who served as Chair since 2013 and will now take on the role of Vice Chair.

Douglas Brodman

Elise Barish

Also on April 1, Elise Barish joined the MRF Board of Directors. l  Barish has been closely involved with the MRF since 2009, when her brother, Dr. David Abrutyn, was honored with a Courage Award at the MRF New York Gala. l  She initiated the MRF Denver Gala in 2012 and remains an active committee member each year.

It has been an incredible honor to have served as Board Chair during such a transformational era for the melanoma community. When I was diagnosed with stage 4 melanoma 17 years ago, there was only one FDA-approved treatment. Today, thanks to innovative research advances like those made possible by the MRF, more than a dozen approved therapies are available to patients. Under Doug’s leadership, I am confident that we will continue to support the development of new, more effective treatments and, one day, a cure for melanoma. — STEVEN SILVERSTEIN “ ”

Steven Silverstein


Made with FlippingBook Ebook Creator